Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. | J Exp Clin Cancer Res | 2023 | 36588164 | PubTator, text mining | PubMed |
| Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. | Sci Immunol | 2023 | 36548397 | PubTator, text mining | PubMed |
| Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. | Nat Immunol | 2023 | 36536106 | PubTator, text mining | PubMed |
| Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. | Nat Rev Immunol | 2023 | 36536068 | PubTator, text mining | PubMed |
| Antibodies to watch in 2023. | MAbs | 2023 | 36472472 | PubTator, text mining | PubMed |
| Development of Effective Siglec-9 Antibodies Against Cancer. | Curr Oncol Rep | 2023 | 36445569 | PubTator, text mining | PubMed |
| Glycobiology of rheumatic diseases. | Nat Rev Rheumatol | 2023 | 36418483 | PubTator, text mining | PubMed |
| Antibodies as drugs-a Keystone Symposia report. | Ann N Y Acad Sci | 2023 | 36382536 | PubTator, text mining | PubMed |
| Human neutrophils ≠ murine neutrophils: Does it matter? | Immunol Rev | 2023 | 36380497 | PubTator, text mining | PubMed |
| Targeting HER2-positive breast cancer: advances and future directions. | Nat Rev Drug Discov | 2023 | 36344672 | PubTator, text mining | PubMed |
| Unlocking the potential of agonist antibodies for treating cancer using antibody engineering. | Trends Mol Med | 2023 | 36344331 | PubTator, text mining | PubMed |
| Brain molecular mechanisms in Rasmussen encephalitis. | Epilepsia | 2023 | 36336987 | PubTator, text mining | PubMed |
| Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial. | J Clin Oncol | 2023 | 36332179 | PubTator, text mining | PubMed |
| Gene Therapy for Occupational Lung Disease: Steering Macrophages in the Right Direction? | Am J Respir Cell Mol Biol | 2023 | 36315436 | PubTator, text mining | PubMed |
| Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches. | Eur J Immunol | 2023 | 36314264 | PubTator, text mining | PubMed |
| In Vitro Generation of Luminal Vasculature in Liver Organoids: From Basic Vascular Biology to Vascularized Hepatic Organoids. | Int J Stem Cells | 2023 | 36310029 | PubTator, text mining | PubMed |
| Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia. | Haematologica | 2023 | 36263841 | PubTator, text mining | PubMed |
| Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis. | Am J Respir Cell Mol Biol | 2023 | 36227848 | PubTator, text mining | PubMed |
| Obesity Exacerbates Lupus Activity in Fc Gamma Receptor IIb Deficient Lupus Mice Partly through Saturated Fatty Acid-Induced Gut Barrier Defect and Systemic Inflammation. | J Innate Immun | 2023 | 36219976 | PubTator, text mining | PubMed |
| The top 100 most cited articles in anaphylaxis: a bibliometric analysis. | Clin Exp Med | 2023 | 36166096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=31